We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$439B
AUM Growth
+$49B
Cap. Flow
+$65.7B
Cap. Flow %
14.98%
Top 10 Hldgs %
33.97%
Holding
14,356
New
1,622
Increased
5,458
Reduced
5,222
Closed
1,858

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$703M
2
TSLA icon
Tesla
TSLA
+$585M
3
JPM icon
JPMorgan Chase
JPM
+$582M
4
AMZN icon
Amazon
AMZN
+$566M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$466M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$349M
2
HD icon
Home Depot
HD
+$334M
3
TMUS icon
T-Mobile US
TMUS
+$270M
4
CI icon
Cigna
CI
+$258M
5
CDW icon
CDW
CDW
+$237M

Sector Composition

Rank Sector Weight
1 Technology 3.12%
2 Healthcare 2.55%
3 Financials 2.39%
4 Consumer Discretionary 2.14%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SURF
11526
CALL
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$52K ﹤0.01%
50,100
-24,100
-32% -$38.5K
MMX
11527
CALL
DELISTED
Maverix Metals Inc. Common Shares
MMX
$52K ﹤0.01%
+15,500
New +$58.7K
ADCT icon
11528
CALL
ADC Therapeutics
ADCT
$129M
$51K ﹤0.01%
10,500
-9,400
-47% -$68.1K
AMBP icon
11529
Ardagh Metal Packaging
AMBP
$3.13B
$51K ﹤0.01%
10,564
-170,351
-94% -$1.04M
APVO icon
11530
Aptevo Therapeutics
APVO
$4.46M
– –
0
– –
BBDO icon
11531
Banco Bradesco
BBDO
$32.9B
$51K ﹤0.01%
17,012
+5,151
+43% +$15K
BLND icon
11532
CALL
Blend Labs
BLND
$352M
$51K ﹤0.01%
23,000
-16,100
-41% -$45.7K
DADA
11533
CALL
DELISTED
Dada Nexus
DADA
$51K ﹤0.01%
10,800
-6,600
-38% -$43.6K
KUST
11534
PUT
Kustom Entertainment Inc
KUST
$771K
– –
0
– –
DPRO
11535
Draganfly
DPRO
$182M
$51K ﹤0.01%
+2,942
New +$65.6K
OLB icon
11536
OLB
OLB
$4.37M
$51K ﹤0.01%
4,818
+3,616
+301% +$47.9K
PBYI icon
11537
CALL
Puma Biotechnology
PBYI
$456M
$51K ﹤0.01%
+21,700
New +$63.4K
SIEB icon
11538
CALL
Siebert Financial
SIEB
$78.9M
$51K ﹤0.01%
34,200
-8,700
-20% -$14.1K
SKYX icon
11539
PUT
SKYX Platforms
SKYX
$152M
$51K ﹤0.01%
+13,900
New +$53.5K
LFLY
11540
PUT
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$51K ﹤0.01%
3,720
+3,030
+439% +$169K
ARDS
11541
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$51K ﹤0.01%
54,386
+34,905
+179% +$54.3K
FVIV.WS
11542
DELISTED
Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVIV.WS
$51K ﹤0.01%
294,022
-482
-0.2% -$79
MACK
11543
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$51K ﹤0.01%
13,718
-2,493
-15% -$11.5K
GASS icon
11544
CALL
StealthGas
GASS
$352M
$50K ﹤0.01%
19,500
+4,900
+34% +$13.5K
ICMB icon
11545
CALL
Investcorp Credit Management BDC
ICMB
$12.1M
$50K ﹤0.01%
13,800
+400
+3% +$1.76K
IDN icon
11546
CALL
Intellicheck
IDN
$56.9M
$50K ﹤0.01%
+19,900
New +$51.2K
IVCAW
11547
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
$50K ﹤0.01%
+501,985
New +$85.5K
LODE icon
11548
CALL
Comstock
LODE
$263M
$50K ﹤0.01%
11,850
+130
+1% +$723
LRMR icon
11549
Larimar Therapeutics
LRMR
$453M
$50K ﹤0.01%
15,601
+1,925
+14% +$4.82K
SABA
11550
Saba Capital Income & Opportunities Fund II
SABA
$220M
$50K ﹤0.01%
6,147
-25,442
-81% -$230K
460 461
462
463 464

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2022 Portfolio in Review

As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.

  • Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
  • Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
  • Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
  • Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
  • Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
  • Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.